Pr Benjamin Besse
- Spécialité
- Oncologue médical, expert poumon
- Titre
- Directeur de la Recherche Clinique
- Hôpital
- Gustave Roussy (Villejuif)
- Derniers articles
-
- Response to letter Re "Morphine and metformin impact immunotherapy benefit in patients with NSCLC: Results of the real-world study IFCT-1502 CLINIVO-SNDS". (9 sept. 2025)
- De-escalation strategies with targeted therapies in non-small cell lung cancer. (1 sept. 2025)
- Lung metastases. (21 août 2025)
- Upfront osimertinib and as sequential therapy in patients with EGFR-mutant non-small cell lung cancer (NSCLC): benefit across patients groups in a real-world retrospective cohort-the smile study. (31 juil. 2025)
- Parallel Phase II Clinical Trials of Selinexor in Patients With Advanced Thymoma and Thymic Carcinoma. (15 mai 2025)